Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infusional vinorelbine in relapsed or refractory lymphomas.
Sarris AH, Psyrri A, Hagemeister F, Romaguera J, McLaughlin P, Rodriguez MA, Bachier C, Younes A, Mesina O, Oholendt M, Medeiros LJ, Samuels B, Adams LM, Cabanillas F. Sarris AH, et al. Among authors: younes a. Leuk Lymphoma. 2000 Oct;39(3-4):291-9. doi: 10.3109/10428190009065828. Leuk Lymphoma. 2000. PMID: 11342309 Clinical Trial.
Irinotecan in relapsed or refractory non-Hodgkin's lymphoma.
Sarris AH, Romaguera J, Hagemeister FB, Rodriguez MA, McLaughlin P, Pro B, Younes A, Mesina O, Cabanillas F, Medeiros LJ, Samuels B. Sarris AH, et al. Among authors: younes a. Oncology (Williston Park). 2001 Jul;15(7 Suppl 8):53-6. Oncology (Williston Park). 2001. PMID: 11497233 Clinical Trial.
Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors.
Zheng B, Georgakis GV, Li Y, Bharti A, McConkey D, Aggarwal BB, Younes A. Zheng B, et al. Among authors: younes a. Clin Cancer Res. 2004 May 1;10(9):3207-15. doi: 10.1158/1078-0432.ccr-03-0494. Clin Cancer Res. 2004. PMID: 15131062
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Goy A, Younes A, McLaughlin P, Pro B, Romaguera JE, Hagemeister F, Fayad L, Dang NH, Samaniego F, Wang M, Broglio K, Samuels B, Gilles F, Sarris AH, Hart S, Trehu E, Schenkein D, Cabanillas F, Rodriguez AM. Goy A, et al. Among authors: younes a. J Clin Oncol. 2005 Feb 1;23(4):667-75. doi: 10.1200/JCO.2005.03.108. Epub 2004 Dec 21. J Clin Oncol. 2005. PMID: 15613697 Clinical Trial.
Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.
Valbuena JR, Rassidakis GZ, Lin P, Atwell C, Georgakis GV, Younes A, Jones D, Medeiros LJ. Valbuena JR, et al. Among authors: younes a. Mod Pathol. 2005 Oct;18(10):1343-9. doi: 10.1038/modpathol.3800459. Mod Pathol. 2005. PMID: 16056252 Free article.
758 results